Table 3.
Long-term follow-up results in 143 patients after oncologic resection for pancreatic ductal adenocarcinoma before (period 1) and after (period 2) S3 guideline implementation.
| Period 1 (09/’03–07/’07) (n = 49) | Period 2 (08/’07–08/’14) (n = 94) | p | |
|---|---|---|---|
| Follow-up results | |||
| Deaths (total) | n = 47 (96%) | n = 67 (71%) | 0.0005 |
| Survivors | n = 2 (4%) | n = 27 (29%) | 0.0005 |
| Tumor recurrence | n = 43 (88%) | n = 74 (79%) | 0.1432 |
| Survival overall a | 17.3 (12–24) | 18.6 (15–22) | 0.3048 |
| Disease free survival a | 11.3 (9–17) | 11.6 (9–13) | 0.9215 |
a
Median survival time, 95% CI (months).